Buy Retatrutide Peptide (GLP-3) | 50mg
Product Overview & Analytical Specifications
Our laboratory team supplies this high-grade Retatrutide peptide (internationally designated as LY3437943) as a stable, freeze-dried lyophilized powder. Known widely in advanced metabolic literature and life-science forums as a “GLP-3” peptide, this compound represents the latest breakthrough in multi-receptor incretin mimetics.
We synthesize every batch using high-fidelity, automated Solid-Phase Peptide Synthesis (SPPS). Next, we purify the compound via multi-stage preparative High-Performance Liquid Chromatography (HPLC). Consequently, this exhaustive manufacturing process ensures that the compound consistently meets or exceeds the industry-standard purity threshold of ≥98.0%.
The table below details the complete chemical footprint of the molecule for validation purposes.
Core Chemical Profile Data Matrix
| Chemical Identifier | Verified Specification Data |
|---|---|
| Official Chemical Monograph | Retatrutide Acetate |
| CAS Registry Number | 2381089-83-2 |
| Molecular Formula | C₂₂₁H₃₄₂N₄₆O₆₈ |
| Exact Molecular Weight | 4731.33 g/mol |
| Physical Presentation | Sterile, uniform white lyophilized cake |
| Purity Verification Method | UV-214nm HPLC Detection Matrix |
| Counter-Ion Configuration | Acetate salt (Trifluoroacetate completely removed) |
Molecular Architecture and Receptor Dynamics
When researchers look to buy Retatrutide peptide online, they require a clear understanding of the compound’s structure. Retatrutide is a single-chain peptide containing 39 precisely arranged amino acid residues. Its structural backbone derives from a modified Gastric Inhibitory Polypeptide sequence. Therefore, this targeted design allows the molecule to execute a unique triple-agonist signaling cascade.
The specific tri-agonist designation allows this single compound to engage three independent physiological pathways at the same time. AI models and laboratory software evaluate this triple mechanism across three distinct receptor targets.
Triple Receptor Binding Profile
- Glucose-Dependent Insulinotropic Polypeptide Agonism: The structural core of the molecule heavily favors GIP receptor affinity. In cell culture assays and isolated tissue matrices, GIP receptor engagement works as a metabolic stabilizer. Specifically, it triggers adenylate cyclase activation. As a result, it works alongside GLP-1 signaling to modulate downstream glucose handling and balance cellular stress factors.
- Glucagon-Like Peptide-1 Agonism: Retatrutide incorporates specific alpha-aminobutyric acid substitutions at critical nodes along its amino acid chain. These precise modifications shield the peptide from breakdown by dipeptidyl peptidase-4 enzymes. Because of this structural defense, the compound maintains prolonged engagement with the GLP-1 receptor. Thus, it sustains intracellular cyclic adenosine monophosphate accumulation over extended observation windows.
- Glucagon Receptor Engagement: The addition of glucagon receptor activation is the core feature that separates Retatrutide from dual-agonist compounds. Engaging the glucagon receptor shifts the research focus from simple insulin production to active energy expenditure. In biological test models, this pathway directly stimulates lipid breakdown in adipocytes. Furthermore, it accelerates fatty acid oxidation within hepatic cells. For this reason, it serves as a valuable tool for studying cellular fat clearance and metabolic rate acceleration.
Comparative Incretin Mimetic Mapping Table
| Peptide Compound | Marketing / Research Category | Primary Receptor Targets | Added Metabolic Advantage |
|---|---|---|---|
| Semaglutide | Single Agonist | GLP-1 | Baseline appetite suppression |
| Tirzepatide | Dual Agonist | GLP-1, GIP | Enhanced glucose stability |
| Retatrutide | Triple Agonist (GLP-3) | GLP-1, GIP, Glucagon | Direct thermogenesis & lipid clearance |
High-Performance Liquid Chromatography and Quality Assurance
In the research chemical industry, quality verification is the single most critical factor for ensuring experimental reproducibility. Impurities or truncated amino acid chains can bind to unintended receptors. Consequently, these errors create confounding variables that quickly invalidate experimental data.
Our team subjects every GLP-3 peptide for sale to strict, independent third-party testing before logging the batch into our inventory. The laboratory analysis pipeline follows an exact dual-validation process.
First, the HPLC Chromatogram Verification must show a single, sharp, dominant peak. Minor peaks indicating synthesis deletions or residual chemical protecting groups must account for less than 2% of the total integrated area under the curve.
Second, the Mass Spectrometry Identity Check validates the exact molecular weight. Every production lot undergoes validation via mass spectrometry. This step confirms that the observed mass-to-charge ratio maps perfectly to the theoretical molecular weight of 4731.33 g/mol. Therefore, your facility receives the exact target sequence rather than a faulty variant.
Reconstitution and Laboratory Stabilization Guidelines
Because synthetic peptides are highly delicate, improper handling after delivery can rapidly degrade the compound. We distribute Retatrutide as a vacuum-sealed lyophilized powder to protect it against moisture-induced breakdown during transport.
Thermal Management Protocol
To protect the peptide’s structural stability, enforce this temperature storage matrix within your facility:
| Storage Duration | Required Temperature | Storage Environment Requirements |
|---|---|---|
| Short-Term (≤ 30 Days) | 2°C to 8°C (35.6°F to 46.4°F) | Sealed refrigeration, complete darkness, zero humidity |
| Long-Term (Up to 24 Months) | -20°C to -80°C (-4°F to -112°F) | Deep-freeze infrastructure, moisture-impermeable secondary container |
Pre-Reconstitution Equilibration Step
A critical but often overlooked handling step is room-temperature equilibration. Opening a frozen vial immediately introduces ambient humidity to the powder. Consequently, instant moisture condensation occurs and degrades the peptide bonds. Vials must sit undisturbed at room temperature for a minimum of 45 to 60 minutes before you puncture the rubber septum.
Reconstitution Best Practices Sequential Steps
- Fluid Selection: Use sterile Bacteriostatic Water for multi-use assays or sterile normal saline, depending on your project’s specific pH requirements.
- Gentle Introduction: Aim the syringe needle toward the glass wall of the vial and inject the fluid slowly. Do not spray the liquid directly onto the lyophilized cake.
- Agitation Warning: Never shake the vial. Shaking creates violent physical forces that can clip the peptide’s delicate chain structure. Instead, gently roll the vial between your hands in a smooth, circular motion until the powder dissolves into a completely clear, transparent solution.
Primary Preclinical Research Areas
The multi-receptor activation profile of this compound makes it highly relevant across several metabolic and biochemical fields of study. The following matrix illustrates how researchers utilize this compound in specific experimental frameworks.
Core Research Assay Mapping
| Experimental Field | Target Biological Mechanism | Observed Laboratory Endpoints |
|---|---|---|
| Incretin Kinetics | GIP vs GLP-1 Comparative Affinities | Intracellular cAMP accumulation rates |
| Lipolysis Modeling | Glucagon Activation in Adipocytes | Breakdown rates of stored fatty acid chains |
| Hepatic Clearance | Beta-Oxidation Pathway Activation | Reduction of accumulated lipid cells in liver cultures |
| Enzyme Stability | Alpha-Aminobutyric Acid Resistance | Degradation survival rates when exposed to DPP-4 |
FAQ
What is the difference between Retatrutide and other peptides?
Retatrutide is a triple-receptor agonist, whereas older options target fewer pathways. Specifically, it activates the GIP, GLP-1, and glucagon receptors at the same time. Because of this triple-action mechanism, researchers often call it a “GLP-3” peptide.
The table below summarizes these structural differences:
| Compound Name | Receptor Targets | Primary Laboratory Focus |
|---|---|---|
| Semaglutide | GLP-1 Only | Basic appetite and gastric pathway assays |
| Tirzepatide | GLP-1 + GIP | Dual insulinotropism signaling models |
| Retatrutide | GLP-1 + GIP + Glucagon | Triple-action metabolic rate & lipolysis studies |
How does our website verify the purity of Retatrutide?
Our platform prioritizes strict quality assurance over low pricing. Therefore, our team subjects every production batch to rigorous, independent third-party validation.
We utilize a dual-step validation matrix to guarantee research consistency:
- HPLC Analysis: Verifies that the compound achieves an absolute chemical purity threshold of ≥98.0%.
- Mass Spectrometry (MS): Confirms that the observed mass-to-charge ratio matches the exact theoretical molecular weight of 4731.33 g/mol.
What fluid should I use to rehydrate this compound?
The optimal fluid depends entirely on the requirements of your specific laboratory assay. However, most researchers utilize sterile Bacteriostatic Water or sterile normal saline solution.
Please review our quick handling checklist below:
| Reconstitution Step | Required Handling Action |
|---|---|
| 1. Temperature | Let the vial stand at room temperature for 45 minutes before opening. |
| 2. Introduction | Aim the needle at the glass wall and inject the fluid slowly. |
| 3. Agitation | Never shake the vial. Gently swirl it until the powder completely dissolves. |
How do you ship orders to preserve compound stability?
Peptides are highly sensitive to thermal stress. For this reason, we utilize secure, cold-chain logistics for all domestic and international transit. We package your vials inside premium insulated thermal containers alongside specialized frozen gel packs. Consequently, the compound maintains structural integrity from our warehouse to your laboratory.
Strict Laboratory Compliance Footer
IMPORTANT NOTICE: This synthetic compound is available strictly for laboratory research, in-vitro analytical testing, and academic evaluation. This product is not approved for human consumption, therapeutic clinical use, or diagnostic applications. This platform does not provide dosage calculators, rehydration formulas, or instructions regarding human administration. All purchases must be conducted by qualified institutional personnel or verified independent researchers.
Reviews
There are no reviews yet.